NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) ("Weight Watchers"), the global leader in science-backed weight management, today announced a collaboration with Google Health Enterprise, combining wearable technology and AI-powered health insights with Weight Watchers' clinically proven weight health program.
NEW YORK, Sept. 09, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers” or the “Company”), the global leader in science-backed weight management, announced today that it has appointed Stephen Bye as its President and Chief Executive Officer and a member of the Company's Board of Directors.
Total End of Period Subscribers of 2.5 million; End of Period Clinical Subscribers of 197 thousand, up 55.7% year-over-year Core+ End of Period Subscribers of 541 thousand, up 13.9% year-over-year, reflecting third consecutive quarter of sequential growth Revenue of $162.3 million; Clinical Subscription Revenue of $39.9 million, up 30.4% year-over-year Reaffirms Full Year 2026 Financial Guidanc...
Sam's Club Plus members may receive a complimentary three-month Weight Watchers Core membership, while all Sam's Club members can save up to 50% on select Weight Watchers programs
NEW YORK, July 08, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers”), the global leader in science-backed weight health, today announced a new summer collaboration with FlavCity, the fast-growing health and wellness brand known for bringing transparency, simplicity, and authenticity to everyday food choices. As Weight Watchers' official protein collaborator of the...
Weight Watchers expands access for Med+ Medicare beneficiaries to GLP-1 medications covered by the Medicare Bridge Program. Weight Watchers expands access for Med+ Medicare beneficiaries to GLP-1 medications covered by the Medicare Bridge Program.
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.